IGF1 and obesity due to melanocortin 4 receptor deficiency: Conventional wisdom suggests that obesity and the development of type 2 diabetes are associated with insulin-resistance and a compensatory increase in insulin levels could then stimulate the growth and metabolism of neoplastic cells via insulin receptors, IR-A or hybrid IGF-I/IR receptors (4, 119).